AstraZeneca

Open: 65.62 Close: 65.9 Change: 0.28

We programmed an AI to read Internet. This is what it found out about AstraZeneca.

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, vaccine, drug, company, Tuesday, Astrazeneca, diabetes, and the …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

Astrazeneca shares inched down 0.10% to £103.46 Tuesday, with the NASDAQ Composite Index rising 0.66% to 15,003.22. Astrazenec settled a lawsuit in the United States totalling US$68.5 million to be divided up to 38 states.

Today's News

AstraZeneca PLC ADR sank 0.08% to $65.90 Tuesday, on what proved to be an all-around positive trading session for the stock market. Astrazeneca shares inched down 0.10% to £103.46 Tuesday, with the NASDAQ Composite Index rising 0.66% to 15,003.22. Astrazeneca to withdraw diabetes drug Forxiga from Korea. AstraZeneca employee failed with his lawsuit alleging he was denied a religious exemption for his Christian faith from the companys Covid-19 vaccine mandate. AstraZeneca to acquire vaccine developer Icosavax. The company has been involved in developing the Oxford–AstraZeneca COVID-19. AstraZeneca acquired US company MedImmune for about US$15.2 billion to gain flu vaccines and an anti-viral treatment for infants. Company announced plans for a major corporate restructuring in 2013. AstraZeneca has its corporate headquarters in Cambridge, United Kingdom, and its main research and development (R&D) centres are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden) and Warsaw (Poland) AstraZecas drug tremelimumab was approved in April 2015. AstraZeneca settled a lawsuit in the United States totalling US$68.5 million to be divided up to 38 states. In 2010, Astra Zeneca agreed to pay £505 million to settle a UK tax dispute related to transfer mispricing. AstraZeneca to pay £2.2bn towards joint venture diabetes deal. AstraZeneca will axe 1,600 jobs in overhaul of drug R&D. Valeant Licenses Brodalumab from Astra Zeneca for Up to $445M. EMA adds Guillain-Barré syndrome as a very rare side-effect of the Oxford-AstraZeneca COVID-19 vaccine (Vaxzevria) in product information. Compugen will be eligible to receive $10 million milestone payment upon dosing of first patient in AstraZeneca phase 3 rilvegostomig trial in biliary tract cancer. Such milestones are closely watched as they often indicate the confidence a larger partner has in the compounds potential.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

How much time have you spent trying to decide whether investing in AstraZeneca? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, vaccine, drug, company, Tuesday, Astrazeneca, diabetes, and the most common words in the summary are: astrazeneca, best, company, news, trial, health, vaccine, . One of the sentences in the summary was: Astrazenec settled a lawsuit in the United States totalling US$68.5 million to be divided up to 38 states.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #best #company #news #trial #health #vaccine.